UNSPSC 51152104: Atropine/hyoscyamine/scopolamine/simethicone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA802. This VA Drug Class (GA802) classifies this compound as belonging to the group ANTIMUSCARINIC/ANTIPASMODIC COMBINATIONS.

UNSPSC 51152104 Atropine/hyoscyamine/scopolamine/simethicone is a Commodity code that in recent state and local procurement activity captures the procurement of naloxone and pharmaceutical products for public health initiatives and pharmacy benefit programs. The code represents a narrow product line, but the recent opportunities show state and local governments buying these medications to support emergency response and community health operations. Issuing bodies include county health departments and state health and human services commissions; Seminole County, Florida and the Texas Health and Human Services Commission both posted opportunities in the code's recent activity.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking to procure 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to solicit vendor capabilities for implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers. Recent activity centers in Florida and Texas, with both opportunities reflecting growing state and local interest in direct pharmaceutical procurement models and emergency medication availability for community health response.